The NICHD distributes its resources among many diverse programs and mechanisms. The institute is committed to funding the largest number of meritorious projects possible, while allowing the flexibility needed to support selected program priorities and respond to emerging scientific opportunities.
When the President signs the NIH Appropriation, the funds for new and competing renewal research grant applications are allocated for the fiscal year. The Institute establishes general guidelines for funding based on the allocation, allowing for necessary adjustments throughout the year to reflect directives from Congress and the NIH, as well as emerging program priorities.
For FY 2009, the following guidance applies to the award of grant funds, reflecting modifications to the original guidance for FY 2009 under a Continuing Resolution:
Information on the American Recovery and Reinvestment Act of 2009 and the NICHD role can be found at Eunice Kennedy Shriver National Institute of Child Health and Human Development Recovery Act Homepage .
The NICHD does not make “across-the-board” budget cuts to grants it intends to fund. However, in the interests of awarding as many grants as possible, adjustments are necessary, in part due to the following factors:
For all R01 awards up to $250,000 per year in direct costs, consideration is given to adjusting the level by an amount up to approximately 17 percent of the direct costs recommended. For awards greater than $250,000 per year, consideration is given to adjusting the level by an amount up to approximately 20 percent of the direct costs recommended. Additional reductions may be discussed with the Principal Investigator, based on factors such as research scope, other support, and program priorities.
For program project grants, the NICHD sets a baseline for new competing applications (Type 1) at approximately 20 percent below the recommended level of support. This baseline serves as a benchmark for negotiations regarding the level of support. Competing continuation (Type 2) applications are funded at a level not to exceed five percent above the last non-competing (Type 5) award.
The non-competing FY 2009 level of support is presented on the FY 2008 award notice and generally reflects a three percent yearly increase. The FY 2009 appropriation allows NIH to support research grants at the most recently committed levels.
Non-competing awards previously issued in FY 2009 at reduced levels will be revised to restore funds to the level consistent with this strategy.
Non-competing (Type 5) SBIR/STTR (R41/42/43/44), Fellowship (F), Training (T), and Career Development (K) grants will be awarded at the full 2009 commitment levels.